Anti-cPR3 Reactivity in Vasculitis Patients
Author Information
Author(s): Tadema Henko, Kallenberg Cees G. M., Stegeman Coen A., Heeringa Peter
Primary Institution: University Medical Center Groningen, University of Groningen
Hypothesis
The study investigates whether anti-cPR3 antibodies are present in patients with PR3-ANCA-associated vasculitis.
Conclusion
Anti-cPR3 reactivity was not increased in PR3-ANCA-associated vasculitis patients compared to control groups.
Supporting Evidence
- Anti-cPR3 reactivity was significantly lower in PR3-ANCA positive patients compared to healthy controls.
- The study used two separate cohorts to confirm findings.
- No significant difference in anti-cPR3 reactivity was found between patients at diagnosis and during follow-up.
Takeaway
The study looked at whether a specific antibody is more common in patients with a certain type of blood vessel disease, but found it wasn't.
Methodology
Anti-cPR3 reactivity was determined using ELISA in serum from patients and healthy controls.
Potential Biases
Potential masking of anti-cPR3 reactivity by idiotypic antibodies.
Limitations
The study's findings await confirmation from other patient cohorts.
Participant Demographics
57 patients with PR3-ANCA-associated vasculitis and 24 healthy controls, age and sex matched.
Statistical Information
P-Value
0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website